Jefferies Financial Group Begins Coverage on Aerovate Therapeutics (NASDAQ:AVTE) : vimarsana.com

Jefferies Financial Group started coverage on shares of Aerovate Therapeutics (NASDAQ:AVTE – Free Report) in a research note issued to investors on Monday morning, Marketbeat.com reports. The firm issued a buy rating and a $65.00 price target on the stock. Separately, Wells Fargo & Company initiated coverage on shares of Aerovate Therapeutics in a research […]

Related Keywords

United States , Alps , Switzerland General , Switzerland , Swiss , Marinus Verwijs , Ralph Niven , Alps Advisors Inc , Silverarc Capital Management , Aerovate Therapeutics Inc , Highvista Strategies , Swiss National Bank , Driehaus Capital Management , Aerovate Therapeutics Company Profile , Securities Exchange Commission , Jefferies Financial Group , Wells Fargo Company , Aerovate Therapeutics , Free Report , Wells Fargo , Exchange Commission , National Bank , Capital Management , Vista Strategies , Get Free Report , Aerovate Therapeutics Daily , Nasdaq Avte , Avte , Medical , Initiated Coverage , Jefferies Financial Group Inc ,